159 related articles for article (PubMed ID: 34464554)
61. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
62. Extensive papillary carcinoma of the thyroid gland treated by external beam radiotherapy, surgery and postoperative radioactive iodine therapy.
Naveed A; Kanaan F; Tjernstrom NO
Eur Arch Otorhinolaryngol; 2009 Nov; 266(11):1837-9. PubMed ID: 19294401
[TBL] [Abstract][Full Text] [Related]
63. Measurement and Variation in Estimation of Quality of Life Effects of Patients Undergoing Treatment for Papillary Thyroid Carcinoma.
Lubitz CC; De Gregorio L; Fingeret AL; Economopoulos KP; Termezawi D; Hassan M; Parangi S; Stephen AE; Halpern EF; Donelan K; Swan JS
Thyroid; 2017 Feb; 27(2):197-206. PubMed ID: 27824301
[TBL] [Abstract][Full Text] [Related]
64. Metachronous solitary metastasis of papillary thyroid cancer in the cavernous sinus: case report and review of literature.
Chandarana MN; Epari S; Chaukar D; Moiyadi AV
J Cancer Res Ther; 2012; 8(3):436-8. PubMed ID: 23174730
[TBL] [Abstract][Full Text] [Related]
65. Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases.
Nunes KS; Matos LL; Cavalheiro BG; Magnabosco FF; Tavares MR; Kulcsar MA; Hoff AO; Kowalski LP; Leite AK
Endocrine; 2022 Mar; 75(3):814-822. PubMed ID: 34665427
[TBL] [Abstract][Full Text] [Related]
66. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
67. Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.
Bohec H; Breuskin I; Hadoux J; Schlumberger M; Leboulleux S; Hartl DM
World J Surg; 2019 Mar; 43(3):818-823. PubMed ID: 30465086
[TBL] [Abstract][Full Text] [Related]
68. Well differentiated thyroid cancer: are we over treating our patients?
Nixon IJ; Shah JP
Eur J Surg Oncol; 2014 Feb; 40(2):129-32. PubMed ID: 24373300
[No Abstract] [Full Text] [Related]
69. Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
Forleo R; Grani G; Alfò M; Zilioli V; Giubbini R; Zatelli MC; Gagliardi I; Piovesan A; Ragni A; Morelli S; Puxeddu E; Pagano L; Deandrea M; Ceresini G; Torlontano M; Puligheddu B; Antonelli A; Centanni M; Fugazzola L; Spiazzi G; Monti S; Rossetto R; Monzani F; Tallini G; Crescenzi A; Sparano C; Bruno R; Repaci A; Tumino D; Pezzullo L; Lombardi CP; Ferraro Petrillo U; Filetti S; Durante C; Castagna MG
Thyroid; 2021 Dec; 31(12):1814-1821. PubMed ID: 34541894
[No Abstract] [Full Text] [Related]
70. Papillary thyroid carcinoma with hyperthyroidism and multiple metastases: A case report.
Zhang LL; Liu B; Sun FF; Li HY; Li S; Zhao LR
Medicine (Baltimore); 2020 Jul; 99(30):e21346. PubMed ID: 32791734
[TBL] [Abstract][Full Text] [Related]
71. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
72. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
Vassilopoulou-Sellin R; Schultz PN; Haynie TP
Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
[TBL] [Abstract][Full Text] [Related]
73. Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
MacKinney EC; Kuchta KM; Winchester DJ; Khokar AM; Holoubek SA; Moo-Young TA; Prinz RA
Surgery; 2022 Jan; 171(1):197-202. PubMed ID: 34666913
[TBL] [Abstract][Full Text] [Related]
74. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
75. Predictive Impact of Metastatic Lymph Node Burden on Distant Metastasis Across Papillary Thyroid Cancer Variants.
Ho AS; Luu M; Shafqat I; Mallen-St Clair J; Chen MM; Chen Y; Jain M; Ali N; Patio C; Filarski CF; Lin DC; Bankston H; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2021 Oct; 31(10):1549-1557. PubMed ID: 34470466
[No Abstract] [Full Text] [Related]
76. Adrenal metastasis secondary to papillary thyroid carcinoma.
Koutkia P; Safer JD
Thyroid; 2001 Nov; 11(11):1077-9. PubMed ID: 11762719
[TBL] [Abstract][Full Text] [Related]
77. Improved Survival After Multimodal Approach with
Wu D; Gomes Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2019 Jul; 29(7):971-978. PubMed ID: 31017051
[No Abstract] [Full Text] [Related]
78. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
79. Treatment of refractory thyroid cancer.
Berdelou A; Lamartina L; Klain M; Leboulleux S; Schlumberger M
Endocr Relat Cancer; 2018 Apr; 25(4):R209-R223. PubMed ID: 29371330
[TBL] [Abstract][Full Text] [Related]
80. Parotid gland involvement as an initial presentation of papillary thyroid carcinoma.
Kilic K; Sakat MS; Gozeler MS; Demirci E
Int J Oral Maxillofac Surg; 2017 Aug; 46(8):965-967. PubMed ID: 28442208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
